⌘K

Sign in Start free

NERVGEN PHARMA CORP. (NGEN) stock — financials, valuation and filings | Moatkeep

NERVGEN PHARMA CORP.

NGEN · Nasdaq

$1.44

Close, 2026-10-29Close, 2026-10-29 · source: Databento · USD · figures not investment advice

Window -75.9%vs low +1.4%vs high -75.9%

Pricethrough 2026-10-29ex-date (0) · fiscal quarter (0)

Fiscal year end: Dec 31

Financials · latest year

CAD millions	FY2025
Net Income	-24

Source: SEC EDGAR (XBRL) · figures in CAD millions

Related companies

MX — MAGNACHIP SEMICONDUCTOR Corp MED — MEDIFAST INC ANTX — AN2 Therapeutics, Inc.SIF — SIFCO INDUSTRIES INC OTLK — Outlook Therapeutics, Inc.HOFT — HOOKER FURNISHINGS Corp SATL — Satellogic Inc.ORGO — Organogenesis Holdings Inc.